122. Superficial siderosis Clinical trials / Disease details
Clinical trials : 3 / Drugs : 3 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000021218 | 2024/09/30 | 26/02/2016 | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis (ECHACISS) | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis (ECHACISS) - ECHACISS | superficial siderosis of CNS | deferiprone administration cochlear implantation | Department of Neurology, Tokyo Medical and Dental University | Department of Neurology, Kouchi University Hospital | Recruiting | 20years-old | Not applicable | Male and Female | 5 | Not applicable | Japan |
| 2 | JPRN-jRCTs031180438 | 01/04/2019 | 27/03/2019 | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis - ECHACISS | Superficial siderosis siderosis, cerebellar ataxia, hearing loss, superficial siderosis | 1. Administration of Deferiprone orally 30mg/kg after every meal for 36 months. 2. Artificial cochlear implantation for severe hearing disturbance | Sanjo Nobuo | NULL | Recruiting | >= 20age old | Not applicable | Both | 50 | N/A | Japan |